Truvada.But earlier this year GlaxoSmithKline announced that injections of the antiretroviral cabotegravir, administered every two months, were more effective at preventing transmission of HIV than Truvada.Read More: PrEP injection every two months proves more effective than daily TruvadaTruvada is already up to 99% effective at preventing transmission of the virus, but GSK’s injections were found to be even more effective — 69% more — so much so that clinical trials were stopped early, and those who had been given Truvada were offered bimonthly injections instead.This week, ViiV Healthcare, which is owned by GSK and developed the injections, announced that the U.S.
Read more on metroweekly.com
Celebsbar.com is a large online platform sharing celebrity gossip and latest showbiz news. Exclusive interviews, fresh photos and videos, breaking news, scandals and more is waiting for you here.
Stay tuned to know everything you wish about your favorite stars 24/7.
Check our daily updates and make sure you don't miss anything about celebrities' lives.
Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic
©2024. All rights reserved.